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Abstract
Purpose: To explore the relationships between
depression, fatigue and QoL among patients diagnosed
with cancer in the West Bank.
Method: This was a descriptive, correlational study. 172
patients with lung, breast, colon, prostate and stomach
cancer participated in the study. Depression, fatigue and
quality of life were assessed for patients who undergoing
chemotherapy. All instruments were reliable and valid.
Results: The mean score for depression was 22 (SD=8).
This indicated that many patients in this study
experienced depression. The participants had moderate
fatigue 51 (SD=39). The same results were found in
quality of life dimensions, as the mean score for
functional scales and global health status ranged from 50
to 73 and for symptom scales ranged from 27 to 45.
Regarding the correlation, the results showed that there
were significant correlation between depression and
fatigue and all quality of life dimensions (all p<0.05).
Conclusion: Depression and fatigue were significantly
correlated with QoL. The impact of depression should be
taken into consideration by health care workers when
designing or planning interventions to improve QoL for
patients with cancer through accurate and early
assessment. The moderate fatigue that patients with
cancer experienced by the disease or by the treatment
should also be taken into account. Each one of the key
variables negatively affects QoL in separate. The
occurrence of them simultaneously may increase the
worse effect on QoL for patients with cancer. Based on
that, depression and fatigue should be assessed for each
patient with cancer.
Keywords: Depression; Fatigue; Cancer; Palestine; Quality
of life
Introduction
Cancer is an emerging disease and is a major cause of death
worldwide [1]. It accounts for 8.2 million deaths in 2012 [1].
Cancer is still a progressive and intractable disease as 50% of
patients with cancer die of their disease [2]. Since cancer
causes severe health problems due to the tumor burden or to
the treatment regimens [3], the treatment modalities for them
not only aim to curability from the disease or increase
longevity but also relieving cancer-related symptoms.
Experiencing such symptoms during daily life make a big
burden on patients with cancer and may affect their physical,
mental and social wellbeing [3]. The number of people living
with cancer after diagnosis is nearly 14.5 million in 2014 in the
United States and is expected to rise [4]. All these factors
highlighted the importance of assessing quality of life (QoL)
among patients with cancer.
Quality of life is the person’s perception and experience of
health-related aspects of life based on assessment of the
physiological, psychological, and situational factors [5]. It is a
multidimensional concept which based on the subjective
experience of the patients [6]. Quality of life studies have
shown evidence that is important for patients with cancer and
their management, and for outcomes of cancer-related
interventions [7]. The survival patients with cancer may
experience many symptoms that affect their sense of well-
being and QoL. A study was conducted by Saadatmand et al.
[8] found that most patients with cancer had a relatively
moderate level of overall QoL. Thweib [9] conducted a study
about patients with cancer to highlight the concept of QoL
through assessing the influences of cancer and chemotherapy
on QoL. The author found that QoL were low on all aspects,
most of the QoL dimensions were less than the half of full
function, and more intense symptoms and negative effects
were found [9]. In another study, Dredei and Mansour [10]
found that QoL was moderate among patients with cancer and
majority of patients had better cognitive functioning than
other aspects of their QoL and most of them suffer from
appetite loss.
Background
Patients with cancer are subject to a number of health
problems and appear as signs and symptoms that are physical
and psychological of nature [11]. The literature showed that
low physical health status, and high levels of depression were
common among patients with cancer [11-14]. The significance
of these problems is mainly related to its profound impact on
patient’s physical, physiological, emotional, social and spiritual
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well-being that consequently, may deteriorate patients’ QoL
[15,16]. Moreover, the literature showed that fatigue and
depression had an effect on patients’ treatment outcomes
[11,13,17,18].
Depression emerges as a reaction to the cancer diagnosis
but it lasts for long time due to treatment and illness signs and
symptoms. Massie [19] found that depression might have
prevalence as high as 38% among patients with cancer.
Depression is also found to be one of the most difficult
psychiatric problems to diagnose in patients with cancer [19].
Vahdaninia et al. [20] conducted a longitudinal study to
investigate psychological distress in patients with breast
cancer following completion of breast cancer treatments. The
authors found that levels of depression decreased over time
(in the first three measurements) but a significant number of
women (22.2%) had elevated depression at the 18-months
follow up (forth measurement). This result suggested that all
women with cancer should be screened for depression
especially who are with other symptoms as pain or fatigue.
Depression has been under-diagnosed, underestimated and
under-treated because many healthcare workers worked
under the assumption that patients with cancer should be
depressed and unfortunately this notion pervades the clinical
situations today [21].
Fatigue and depression are highly prevalent among patients
with cancer. They have a detrimental effect on patients’ QoL
[22]. About 66% of patients with breast cancer suffer from
fatigue after diagnosis and extends beyond treatment end
[23]. Fatigue is a multidimensional symptom that affects
various aspects of life for patients with cancer [24]. A study
found a moderate effect of fatigue among patients with breast
cancer and significant correlations among fatigue, depression
and body image [25]. Fatigue is increased among patients with
cancer as the treatment begins. A study compared the level of
fatigue between pretreatment and during treatment for
patients with breast cancer. They found that those who
experience more fatigue at the beginning of treatment tend to
experience worse symptoms later. This highlights the
importance of assessing fatigue among patients with cancer. 
World Health Organization [26] stated that cancer incidence
will increase in the coming 15 years in the Eastern
Mediterranean region. Regarding Palestine, cancer is the
second leading cause of death in Palestine [27]. In 2011, a total
of 1350 cancer cases were reported including 631 males
(46.7%) and 719 (53.3%) females [27].
The issue of having patients receive adequate health care is
a milestone for health care professionals and agencies.
However, the literature showed that diagnostic and treatment
approaches for patients with cancer are overwhelming them
and causing further physical and psychological deteriorations
[28]. There is a need to explore factors that connect and
influence the psychological and physical health status with
patients’ QoL. This study came to address these issues that
have been scarcely addressed in the Arab region and in
Palestine in particular. The study will expand our knowledge
about the interrelationship among these factors within the
Palestinian context. Therefore, this study aimed to explore the
relationships between depression, fatigue and QoL among
patients diagnosed with cancer in the West Bank.
Methodology
Design
The study utilized a cross-sectional, descriptive-correlational
design using survey method for obtaining data about fatigue,
depression and quality of life from patients diagnosed with
lung, breast, colon, stomach and prostate cancer in the West
Bank, Palestine. Data in this study was elicited from the
participants using self-reported questionnaires format. The
study utilized well-established, reliable and valid measures of
these constructs.
Population and sample
All Palestinian patients diagnosed with cancer represented
the potential population of this study. Nonprobability,
convenience sampling technique was used to recruit the
subjects in this study. Potential participants were all patients
who undergoing chemotherapy either in the day care or
admitted in the oncology ward. The inclusion criteria were: 1)
patients with confirmed medical diagnosis of lung, breast,
stomach, colon and prostate cancer, 2) were aged 18 years or
older, and 3) were able to read and write Arabic. The patients
were excluded if they 1) have comorbidities diseases (i.e.,
chronic renal failure, heart failure, mental or cognitive
disorder), 2) have a history of a second primary tumor, and 3)
are receiving chronic antidepressant therapy as it could affect
the perceived level of depression among the participants.
Setting
The two healthcare centers, in the West Bank, that provide
care to patients with cancer were targeted to recruit the
sample. The first center is in the south of the West bank and
the second center is in the north of the West Bank. Both
centers have no radiotherapy treatment modality. The two
centers just provide chemotherapy and surgeries as modalities
for the management of patients with cancer. The two centers
are public ones and the ministry of health is the responsible
agency.
Instruments
First, the sociodemographic questionnaire was developed
by the researcher to acquire information about the
participants’ characteristics. This questionnaire assessed
information about age, marital status, gender, educational
background, types of cancer and duration of diagnosis.
The major variables were measured by the following
instruments:
The center for epidemiological studies depression scale
The Center for Epidemiological Studies Depression Scale
(CES-D) was developed to assess depression [29]. Since its
publication, the scale has been used most frequently to
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measure depression symptoms among patients with non-
cancer and cancer [30-32]. It is a 20-item self-report scale.
Participants were asked to rate each item on a 4-point Likert
scale, seldom or never (0), sometimes or a little (1), regularly
(2) to the most of the times or always (3). Four items (4, 8, 12
and 16) are worded in a positive direction to control for
response bias. The total score is calculated by reversing scores
of the positively worded items, then summing all of the scores.
The range of CES-D score is 0 to 60, with higher scores
indicating more severe depression [33]. A score of 15 or less
indicates that there is no depression, 16 to 21 indicate that
mild to moderate depression, and scores of greater than 22
indicate possibility of major depression. The scale has high
psychometric properties [34].
The european organization for research and treatment of
cancer quality of life questionnaire-C30 (EORTC-C30)
The (EORTC-C30) was established to measure QoL for
patients with cancer [35]. The EORTC-C30 version-3 scale was
used to measure QoL in the current study. The EORTC-C30, a
30-item questionnaire has three dimensions; functional scales,
global health status and symptom scales. Patients were asked
to respond to each item on a Likert type scale ranging from 1
to 4 except the last two items in the global health status which
ranges from 1 to 7. All scores were ranged from 0 to 100. A
high score of the functional subscale and global health status
represent high levels of the functioning and high QoL, but a
high score of symptom scales represent high levels of
symptomatology. The European Organization for Research and
Treatment of Cancer Quality of Life Questionnaire-C30 is a
highly validated and reliable measure [36]. In the current
study, the reliability was assessed by Cronbach’s alpha
coefficient, in which the values were all > 0.70, with the
exception of cognitive function and pain (α = 0.67 and 0.51
respectively).
Nottingham health profile (NHP)
The Nottingham Health Profile is a survey used to measure
perceived physical, emotional, and social aspects of health
[37]. Part I of the survey measures six dimensions of health
including: social isolation, emotional reactions, energy level,
physical mobility, pain and sleep. Between 3 and 8 items are
associated with each dimension [37]. For the purpose of the
current study, energy dimension was used to measure fatigue.
Scores range from 0 to 100. A higher score indicates more
fatigue [38]. The NHP has high validity and reliability [39].
Data collection procedure
After ethical approval was obtained from the targeted
institutions. Participants were recruited and informed about
the study and that their participation is voluntary and that
they have the right to withdraw at any time during the study.
They also informed that their responses will be securely
confidential and anonymous. The participants were asked to
read the cover letter. The cover letter included information
about the purpose of the study, its significance, and all ethical
related information. Data collection started at the beginning of
June 2013 and continued until the end of September 2013 to
reach the targeted sample size which was 150 participants.
However, the actual sample was 172 participants. The targeted
health centers were contacted to ask for their permission to
collect data from patients in their units. The letter to the
selected healthcare centers included a request to assign a
private room where patients can be contacted to fill out the
questionnaires at their convenience. The eligibility criteria
were checked by reviewing the patients’ charts after taking
their permission. A package of four self-report questionnaires
was distributed to the participants who expressed their
interest in the participation in the study. The participants were
instructed that their completion of the questionnaire will be
considered as a written consent for their participation.
Furthermore, the data was kept in a closed cabinet at the
Faculty of Nursing- Birzeit University for which no one but the
researcher has access to. Data collection was conducted from
the patient during their visits to the health center and the time
for filling the questionnaires took about 12 minutes. The
whole package was presented in Arabic language.
Data analysis
Data was analyzed using Statistical Package for Social
Sciences (SPSS) software program version 19, data was
screened for missing data. Univariate statistics were used to
describe the mean, standard deviation, frequency and
percentage of the sample regarding demographic variables,
depression, fatigue, and QoL. Assessing the variables for
normality and outliers were done to detect the assumptions of
inferential tests. Pearson correlation Coefficient (Pearson r)
was used to test the correlation between selected factors and
indicators and to determine associations between
demographics and key study variables. The t-test for two-
independent samples and ANOVA were used to test for
difference in depression, fatigue and QoL among the patients.
Also t-test for two-independent samples was used to examine
the difference between patients in relation to selected
demographic and personal factors.
Results
As shown in Table 1. A total of 172 patients participated in
this study. The average age for the sample was 53 years old.
Females represented 59% (n=102) of the sample compared
with males 41% (n=70), 70% were married, and 68% were
unemployed. In relation to the level of education, most of the
participants 74% (n=127) had high school education or less.
The highest type of cancer was the breast cancer 25% (n=43).
The median for the period of diagnosis was 6 months (Table
1).
The mean score for depression among patients with cancer
was 22 (SD=8). The score above 15 is considered moderate
depression and above 21 is considered major depression [29].
This indicated that majority of the participants had
experienced depression (Table 2). About a quarter of patients
had a score of 16 and less, 75% (n=129) with score of 27 and
less (Table 3). The results showed that the mean score for
fatigue was 51 (SD=39), 70% of the sample scored less than 70
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(Table 3). These results indicated that high percentage of
participants experienced low energy level (Table 4).
Table 1 Demographic characteristics of the sample (N=172).
Variable n % M SD P50 Min Max
Age (years) -- -- 53.5 15.3 55 20 83
Gender
Male 70 40.7 -- -- -- -- --
Female 102 59.3
Marital status
Single 24 14 -- -- -- -- --
Married 121 70.3
Divorced 10 5.8
Widow 17 9.9
Level of Education
High school or less 127 73.8 -- -- -- -- --
Diploma 18 10.5
Baccalaureate 24 14
Graduate 3 1.7
Working Status
Unemployed 117 68 -- -- -- -- --
Full time job 27 15.7
Part-time job 12 7
Retired 16 9.3
Type of Cancer
Lung 33 19.2
Breast 43 25 -- -- -- -- --
Colon 37 21.5
Liver 30 17.4
Stomach 29 16.9
Duration of diagnosis (months) -- -- 9 8.8 6 1 36
Hospitals
North 79 46
South 93 54
Table 2 Descriptive characteristics of the depression, fatigue and quality of life functional scales, global health status and
symptom scales (N=172).
Variable M SD Range P25 P75
Depression 21.7 7.9 44 16 27
Fatigue 50.9 39.3 100 11.2 69.8
Functional Scales
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Physical functioning 59.7 30.9 100 33.3 86.7
Role functioning 65.3 31.5 100 50 100
Emotional functioning 66.8 27.3 100 50 91.7
Cognitive functioning 73.1 28.9 100 50 100
Social functioning 65.8 31.2 100 33.3 100
Global health status 52.1 26.8 100 33.3 66.7
Symptom Scales
Fatigue 44.6 29.1 100 22.2 66.7
Nausea and vomiting 36.8 33.2 100 35.4 56.2
Pain 41.9 27.2 100 16.7 66.7
Dyspnea 34.9 32.4 100 15.5 64.3
Insomnia 46.7 36 100 33 67
Appetite loss 46.3 35.2 100 33.3 66.7
Constipation 31.4 37.2 100 19.7 67
Diarrhea 27.3 34 100 0 33.3
Financial difficulties 37 34.1 100 0 66.7
Table 3 Descriptive characteristics of depression level (N=172).
Depression Level n %
Not depressed 42 24.4
Mild to moderate depression 44 25.6
Major depression 86 50
Table 4 Descriptive characteristics of fatigue items for
participants who responded yes to each question (N=172).
Items Frequency Percentage
1.       I am tired all the time. 62 33.7
2.       Everything is an effort. 118 64.1
3.       I soon run out of energy. 74 40.2
Regarding the quality of life, the highest functioning was for
cognitive functioning (m=73, SD=29) and the lowest one was
social functioning (m=66, SD=31). Global health status was
moderate (m=52, SD=27). In relation to the symptom scales,
the highest symptom experienced by patients was insomnia
(m=47, SD=36). These results showed that majority of the
patients had moderate physical functioning and global health
status and experienced many symptoms that affect their
perceived QoL.
Inferential analysis
In relation to gender differences, t-test was used to assess
the differences between male and female regarding
depression, energy and QoL. The analysis showed that there
were significant differences between male and female
participants regarding depression (t=-2.51, p=0.01), period of
diagnosis (t=2.17, p=0.03), cognitive functioning (t=3.16,
p<0.01), social functioning (t=2.50, p=0.01), and financial
difficulties (t=-2.50, p=0.01). The mean scores were higher
(less functioning and more difficulties) among female
participants. Regarding the two settings, there were no
statistical differences among the variables (all p>0.05). One-
way ANOVA was conducted to assess the differences in types
of cancer across the study variables. It was found that there
were significant differences in types of cancer across nausea
and vomiting (f=2.95, p=0.02), dyspnea (f=5.06, p<0.01) and
loss of appetite (f=5.21, p<0.01). After post hoc analysis was
done, it was found that most of these differences were
attributed to lung cancer. In relation to the job, there were
significant differences between who work full time job and
who does not work across physical functioning (f=2.97, p=0.03)
and cognitive functioning (f=2.79, p=0.04) with better score for
full time job group. A significant difference is also found across
groups of education, the less educated the participant the
more fatigue they perceive (f=3.75, p=0.003). Regarding types
of cancer, it was found that there were significant differences
among types of cancer in nausea and vomiting (f=2.95,
p=0.022), dyspnea (f=5.06, p<0.01), and loss of appetite
(f=5.21, p<0.01). Post hoc analysis showed that there were
significant differences in nausea and vomiting between lung
and stomach with the other types of cancer. Nausea and
vomiting was experienced more in patients with lung and
stomach cancer. The differences in dyspnea and loss of
appetite were attributed by lung cancer compared with the
other types of cancer.
A Bivariate Pearson correlation analysis was done to
examine the associations among depression, age, period of
diagnosis, fatigue and QoL subscales. The results showed that
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there was a significant positive correlation between fatigue
and depression (r=0.448, p<0.01). This indicated that an
increase in depression is associated with high fatigue. Age had
significant negative associations with physical, role and
cognitive functioning of QoL. Age has also significant positive
correlation with pain (r=0.16, p=0.04) and dyspnea (r=0.166,
p=0.029) in symptoms scales of QoL (Table 5).
Table 5 Intercorrelations among age, depression, fatigue,
period of diagnosis and quality of life subscales (N=172).
Variable Age
Period of
Diagnosis Fatigue Depression
Functional scales
PF -0.38** - 0.21 ** -0.53** -0.47**
RF -0.23** -0.1 -0.36** -0.37**
EF -0.11 -0.20** -0.50** -0.61**
CF -0.22** -0.13 -0.39** -0.45**
SF -0.06 -0.05 -0.35** -0.47**
GHS -0.11 -0.17* -0.39** -0.46**
Symptom scales
FA 0.15 0.23** 0.59** 0.49**
NV -0.02 0.19* 0.44** 0.35**
PA 0.16* 0.18* 0.46** 0.49**
DY 0.17* 0.18* 0.36** 0.33**
SL 0.14 0.15* 0.43** 0.45**
AP 0.13 0.14 0.41** 0.36**
CO 0.13 -0.01 0.30** 0.20**
DI 0.02 0.09 0.17* 0.20**
FI 0.07 0.15 0.29** 0.34**
**Correlation is significant at the 0.01 level (2-tailed).
*Correlation is significant at the 0.05 level (2-tailed).
PF: Physical Functioning; RF: Role Functioning; EF: Emotional Functioning;
CF: Cognitive Functioning; SF: Social Functioning; GHS: Global Health
Status; FA: Fatigue; NV: Nausea and Vomiting; PA: Pain; DY: Dyspnea; SL:
Insomnia; AP: Appetite Loss; CO: Constipation; DI: Diarrhea; FI: Financial
Difficulties
This indicated that increasing in age is associated with
worsening pain and dyspnea and decrease in physical, role and
cognitive functioning. Regarding period of diagnosis, it was
found that there were significant negative correlations with
physical, emotional and global health status and positive
correlations with fatigue, nausea and vomiting, pain, dyspnea
and insomnia. This indicated that an increase in period of
diagnosis is associated with worsening symptom scales and a
decrease in functional scales of QoL. In relation to the fatigue,
it was found that fatigue has significant negative associations
with all functional scales and global health status and positive
associations with all symptom scales of QoL. Depression had
also significant negative relationships with all functional scales
and global health status and positive correlations with
symptoms scales of QoL (Table 5). The more the patient
depressed the high fatigue and the more he experienced low
functional scales and worse symptom scales of QoL.
Discussion
Cancer is one of the major causes of death among
Palestinian population [27]. Literature shows that cancer is a
progressive disease that causes severe health problems due to
the disease itself or the treatment modalities, thus
substantially affects the QoL for patients. As cancer is
intractable disease, QoL becomes a very important outcome
for patients with cancer.
The results of this study indicate that a significant
proportion of Palestinian patients with cancer have moderate
to severe depression and experience moderate fatigue. These
factors were significantly correlated with QoL dimensions. The
Palestinian patients with cancer tend to have better cognitive
functioning than physical functioning. In relation to the
symptom scales, the worst symptom was appetite loss (M=47)
and the best symptom was diarrhea (M=26) and constipation
(M=31). This means that more patients complain of appetite
loss in comparison with other symptoms. The results also
showed that about half of the sample had severe depressive
symptoms. One possible explanation is that cancer is
negatively perceived by patients and patients account heavily
on the consequences of treatments such as sessions of
chemotherapy and biophysical changes in their body and
appearance [40]. The reported level of depression also could
be due to the overestimation by self-reports from patients
with cancer or due to the Palestinian cultural background. The
results of this study agree with previous results in that
depression is not uncommon among patients with cancer.
According to Brown and associates [41] 44% of their sample of
patients with cancer reported severe level of depression, while
Pud [40] found that depression incidence among Israeli
patients with cancer was 38% [40]. Previous studies have also
found that the majority of their sample of patients with cancer
had moderate to severe depression that corresponds with the
findings in this study [19,42]. Fatigue is also experienced by
many patients with cancer. It is significantly correlated with
depression. This indicated that fatigue appears in conjunction
with depression. These results are consistent with previous
studies [43-45]. Sawada et al. [46] found that many patients
experienced fatigue and depression and their levels increased
after beginning of the treatment.
This study also found differences between males and
females in their reports of depression that also corresponds
with previous studies [3,47]. Kroenke et al. found significant
difference between male and female regarding the depression
in patients with cancer with more symptoms among female
patients. This may be attributed to the fact that females
experienced the signs and symptoms of the disease in a worse
way than male besides that they are emotionally sensitive
more than male [3]. However, Yamagishi et al. [48] had found
that there were no significant differences between males and
females regarding depression and QoL. They have also
reported that there were no differences between patients'
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reports of depression and quality of life in regards to type of
cancer and demographic characteristics.
The results of this study show that the sample had a
relatively moderate level of overall QoL. This result may be
explained by the signs and symptoms that are experienced by
the patients or due to the treatment modalities. These results
were consistent with other studies [8,49]. However, in another
study, QoL was found to be low on all aspects; most of the
dimensions of QoL were less than half of full function, and
more severe symptoms were found [9]. One possible
explanation for that was due to the sample characteristics (i.e.,
the differences in duration of diagnosis). Despite the
differences in the types of cancer, many studies had found
almost the same results regarding the symptoms scales
[50,51].
Depression was found to be associated with all domains of
QoL in patients with cancer. In fact, diagnosis of cancer and the
treatment of cancer with its collateral side effects produce
psychological disturbances that are related and affected QoL.
These results were consistent with other studies [41,52].
Cataldo et al. [53] indicated that high level of depression was
associated with low levels of QoL. Alacacioglu et al. [54] stated
that the functional scales and global health status of QoL for
depressive patients were significantly lower than that of non-
depressive patients with cancer.
Conclusion
Depression and fatigue were significantly correlated with
QoL. The high prevalence of depression is still thought to be
normal among patients with cancer. This belief that exists in
the clinical situations should be changed. Whatever the origin
of the cognitive, emotional and social distress, the impact of
depression should be taken into consideration by health care
workers when designing or planning interventions to improve
QoL for patients with cancer through accurate and early
assessment. The moderate fatigue that patients with cancer
experienced by the disease or by the treatment should also be
taken into account. Each one of the key variables negatively
affects QoL in separate. The occurrence of them
simultaneously may increase the worse effect on QoL for
patients with cancer. Based on that, assessing these factors
and early intervention may lead to alleviation of these
symptoms which enhance QoL for these patients.
The treatment for cancer are growing and improving. This
led to increase in the survival of patients with cancer. Quality
of life for those patients should be the outcome measure to
assess the disease progression and treatment efficacy. The
QoL for patients is affected by their perception. Patients with
cancer are interested in their wellbeing and QoL. They have
their own beliefs, practices, and thoughts toward their current
status. The impact of depression affected their psychological
status and thus their QoL will be compromised. The same goes
for fatigue, as the physical abilities deteriorated with time, the
patients with cancer became more and more dependent on
their primary caregivers and more symptoms appeared as
depression and this will further distort their QoL.
This study has different limitations; 1) the convenience
sampling method that was used makes the generalizability of
the results of the study to be taken with precautions. It may
make the target sample biased and not representative, 2) the
inclusion of different types of cancer, as each type may have its
own factors, mechanisms and signs and symptoms, and this
may affect the QoL in different ways. For example, lung cancer
may affect dyspnea more than stomach cancer. This may affect
QoL perception by patients with those two types of cancer, 3)
cross-sectional design is also a potential limitation as this
study may give more extensive and significant information if
longitudinal design is used and 4) this study depended upon
using self-report scale by participants to rate their perceptions
regarding physical, psychological factors and QoL.
Relevance for clinical practice
The curriculum in the undergraduate and graduate level of
nursing education should include the evidence-based
regarding caring for patients with cancer. In addition, ongoing
educational programs for clinical practice should consider
guidelines for the importance of assessment and treatment of
depression, fatigue and their impact on QoL for patients with
cancer. Nursing should realize the importance of treating and
caring for patients with fatigue and depression. Furthermore,
it is important for nursing to help the patients with cancer to
reach the lowest level of fatigue which may lead to optimum
QoL.
Education of patients and their families regarding
depression and fatigue and their effect on QoL could help
them to manage their symptoms more effectively and express
their feelings and perception in clearer way which may
enhance their QoL. They should be encouraged to report their
depression and their perceived level of fatigue. The patients
with cancer also should be educated about depression and be
aware that they do not have to live with depression, because
many health care workers and patients still believe that there
is no treatment for it.
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